Bristol-Myers signs deal with UN group for generic hep C drug

Nov 23 (Reuters) - A United Nations-backed organization working to cut the price of HIV drugs said it had signed a deal with Bristol-Myers Squibb Co to allow generic versions of the company's hepatitis C drug to be sold in 112 low- and middle-income countries.